Mode
Text Size
Log in / Sign up
N/A N=43 Health Services Research

BRITEPath, Component 3 of iCHART (Integrated Care to Help At-Risk Teens)

Depression · Suicidal Ideation

Enrolled (actual)
43
Serious AEs
0.0%
Results posted
Aug 2022
Primary outcome: Primary: Depression Severity — 12.9; 9.2 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
BRITEPath (Behavioral)
Age
Pediatric, Adult · 12+ yrs
Sex
All
Sponsor
University of Pittsburgh
Primary completion
Feb 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Depression Severity
10.4; 9.5
PRIMARY
Depression Severity
10.4; 9.5
PRIMARY
Depression Severity
10.4; 9.5
PRIMARY
Suicidal Ideation and Behavior
0.6; 0; 0; 0; 0.1; 0
PRIMARY
Suicidal Ideation and Behavior
0.6; 0; 0; 0; 0.1; 0
PRIMARY
Suicidal Ideation and Behavior
0.6; 0; 0; 0; 0.1; 0
PRIMARY
Quality of Life and Social/Emotional Functioning
72.6; 65.5
PRIMARY
Quality of Life and Social/Emotional Functioning
72.6; 65.5
PRIMARY
Quality of Life and Social/Emotional Functioning
72.6; 65.5
SECONDARY
Application Utilization
28; 10; 28; 10; 34; 4
SECONDARY
Application Utilization
28; 10; 28; 10; 34; 4
SECONDARY
Service Utilization (Outpatient, School, ER, Legal, Inpatient, Medication) - BRITEPath vs. Treatment as Usual (TAU) at Baseline
32; 4; 18; 4; 12; 0
SECONDARY
Service Utilization (Outpatient, School, ER, Legal, Inpatient, Medication) - BRITEPath vs. Treatment as Usual (TAU) at 4 Week Follow Up
31; 4; 19; 4; 12; 0
SECONDARY
Service Utilization (Outpatient, School, ER, Legal, Inpatient, Medication) - BRITEPath vs. Treatment as Usual (TAU) at 12 Week Follow Up
29; 2; 4; 0; 0; 0
SECONDARY
Usability and Satisfaction
5.7; 6.2; 6.1; 6.5; 5.8; 1.8
SECONDARY
Usability and Satisfaction
5.7; 6.2; 6.1; 6.5; 5.8; 1.8
SECONDARY
Cost Estimate for Implementation of BRITEPath Intervention
457.43

Summary

BRITEPath (BP) aims to support co-located mental health clinicians in the development of a high quality, effective, and personalized safety plan for referred patients who screen positive for depression and/or suicidal ideation. BRITEPath utilizes BRITE, a safety planning and emotion regulation app that is loaded on the patient's smart phone and has previously been shown to be well accepted and to reduce suicide attempts compared to usual care in psychiatric inpatients (HR = 0.49). To support mental health clinicians in the development of effective safety plans, study investigators will develop Guide2Brite (G2B), which provides step-by-step instructions for the mental health clinician on how to populate BRITE onto the patient's smartphone and BRITEBoard, a clinician dashboard that tracks patient symptoms, app use, and rating on helpfulness of different interventions assessed through BRITE.

Eligibility Criteria

Inclusion Criteria

  • Youth aged 12-26 yo
  • Own a device (e.g. smartphone, ipod, tablet) with capability to download BRITE app
  • Biological or adoptive parent is willing to provide informed consent for teen to participate
  • Youth speaks and understands English
  • Positive PHQ score or provider determines youth has depressive symptoms based on clinical interaction and refers youth to the study (in cases when PHQ is not available and study staff will complete the PHQ during the screening) OR Provider can refer if they are unclear if symptoms are depressive and PHQ scoring will be used to determine youth's eligibility. OR Screening Wizard screening questionnaire (which includes the PHQ and depressive symptom questions) indicates depression OR provider/parent have concern that youth/patient has a mood or behavioral problem
  • Family agrees to see an (embedded) MH therapist at the practice

PHQ scores:

Score of 8 or higher on PHQ-8 -or- Score of 1 or higher on #9 of PHQ-9 suicidality item

Exclusion Criteria

Non English speaking No parent willing to provide informed consent No cell phone capability of downloading BRITE app Is currently experiencing mania or psychosis Evidence of an intellectual or developmental disorder (IDD) Life threatening medical condition that requires immediate treatment (included emergent suicidality, homicidality, abuse/neglect, or other mental or physical condition) Other cognitive or medical condition preventing youth from understanding study and/or participating.

Currently receiving MH treatment/currently satisfied with treatment

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04000399). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search